Efficacy and safety of ustekinumab in patients with refractory Crohn's disease: data from a real world study in Brazil

被引：0

作者：

Rogerio, Parra ^{[1
]}

Julio, Chebli ^{[2
]}

Liliana, Chebli ^{[3
]}

Erika, Bertges ^{[3
]}

Antonio Jose, Alves Junior ^{[4
]}

Junior Orlando, Ambrogini ^{[5
]}

Tarcia, Gomes ^{[6
]}

Marley, Feitosa ^{[1
]}

Omar, Feres ^{[1
]}

Joaquim, Rocha Jose ^{[1
]}

机构：

[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Ribeirao Preto, SP, Brazil

[2] Univ Fed Juiz de Fora, Ctr Inflammatory Bowel Dis, Juiz De Fora, Brazil

[3] Univ Fed Juiz de Fora, Juiz De Fora, Brazil

[4] Reis Neto Clin, Campinas, SP, Brazil

[5] Hosp Israelita Albert Einstein, Sao Paulo, Brazil

[6] Univ Fed Sao Paulo, Sao Paulo, Brazil

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷

关键词：

D O I：

10.14309/01.ajg.0000578228.17072.6c

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P039

引用

页码：S11 / S11

页数：1

共 50 条

[21] Real World Ustekinumab Use in Pediatric Patients With Crohn's Disease
Ritter, Timothy E.
Sarles, Harry E.
Whitney, Annette E.
Kim-Romo, Dawn N.
Van Anglen, Lucinda J.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1056 - S1056
[22] DISCONTINUATION OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: MULTI-CENTRE REAL WORLD DATA
Fenech, Valerie Anne
Kamperidis, Nikolaos
Hart, Ailsa
Thoua, Nora
Cole, Alexander
Segal, Jonathan
Peake, Simon
Arebi, Naila
GUT, 2021, 70 : A93 - A94
[23] USTEKINUMAB TREATMENT STRATEGIES IN REFRACTORY CROHN'S DISEASE: REAL-WORLD EFFECTIVENESS DATA FROM A UK IBD CENTRE
Harris, Richard
McDonnell, Martin
Bettey, Marion
Downey, Louise
Young, David
Felwick, Richard
Gwiggner, Markus
Cummings, Fraser
GUT, 2019, 68 : A72 - A73
[24] Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort
Plevris, Nikolas
Fulforth, James
Siakavellas, Spyros
Robertson, Andrew
Hall, Rebecca
Tyler, Amy
Jenkinson, Philip W.
Campbell, Iona
Chuah, Cher Shiong
Kane, Claire
Veryan, Jennifer
Lam, Wai Liam
Saunders, Jayne
Kelly, Christopher
Gaya, Daniel
Jafferbhoy, Hasnain
Macdonald, Jonathan C.
Seenan, John Paul
Mowat, Craig
Naismith, Graham
Potts, Lindsay F.
Sutherland, Diarmid Ian
Watts, David
Arnott, Ian
Bain, Gillian
Jones, Gareth
Lees, Charlie W.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (08) : 2067 - 2075
[25] Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Chaparro, Maria
Baston-Rey, Iria
Fernandez-Salgado, Estela
Gonzalez Garcia, Javier
Ramos, Laura
Diz-Lois Palomares, Maria Teresa
Arguelles-Arias, Federico
Iglesias Flores, Eva
Cabello, Mercedes
Rubio Iturria, Saioa
Nunez Ortiz, Andrea
Charro, Mara
Ginard, Daniel
Duenas Sadornil, Carmen
Merino Ochoa, Olga
Busquets, David
Iyo, Eduardo
Gutierrez Casbas, Ana
Ramirez de la Piscina, Patricia
Maia Bosca-Watts, Marta
Arroyo, Maite
Jose Garcia, Maria
Hinojosa, Esther
Gordillo, Jordi
Martinez Montiel, Pilar
Velayos Jimenez, Benito
Quilez Ivorra, Cristina
Vazquez Moron, Juan Maria
Maria Huguet, Jose
Gonzalez-Lama, Yago
Munagorri Santos, Ana Isabel
Manuel Amo, Victor
Dolores Martin-Arranz, Maria
Bermejo, Fernando
Martinez Cadilla, Jesus
Rubin de Celix, Cristina
Fradejas Salazar, Paola
Lopez San Roman, Antonio
Jimenez, Nuria
Garcia Lopez, Santiago
Figuerola, Anna
Jimenez, Itxaso
Martinez Cerezo, Francisco Jose
Taxonera, Carlos
Varela, Pilar
de Francisco, Ruth
Monfort, David
Molina Arriero, Gema
Hernandez Camba, Alejandro
Javier Garcia-Alonso, Francisco
INFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : 1725 - 1736
[26] Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease
Huff-Hardy, Kayci
Bedair, Mai
Vazquez, Rebecca
Burstein, Ezra
INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : E49 - E49
[27] USTEKINUMAB INDUCES CLINICAL AND BIOLOGICAL REMISSION IN BIOLOGIC REFRACTORY CROHN'S DISEASE PATIENTS: A REAL WORLD BELGIAN COHORT STUDY
Liefferinckx, Claire
Verstockt, Bram
Gils, Ann
Noman, Maja
Van Kemseke, Catherine
Elisabeth, Macken
De Vos, Martine
Van Moerkercke, Wouter
Rahier, Jean-Francois
Bossuyt, Peter
Dutre, Joris
Humblet, Evelien
Staessen, Dirk
Peeters, Harald
Van Hootegem, Philippe
Louis, Edouard
Franchimont, Denis
Baert, Filip J.
Vermeire, Severine
GASTROENTEROLOGY, 2018, 154 (06) : S830 - S831
[28] Long-term real-world data of ustekinumab in Crohn's Disease - the Stockholm ustekinumab study - STOCUSTE
Bello, F.
Lordal, M.
Johansson, F.
Sabhan, H.
Muhsen, S.
Borin, A.
Forsberg, O.
Wennerstrom, C.
Soderman, C.
Almer, S.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I130 - I131
[29] Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience
Wils, P.
Bouhnik, Y.
Michetti, P.
Flourie, B.
Brixi, H.
Bourrier, A.
Allez, M.
Duclos, B.
Serrero, M.
Buisson, A.
Amiot, A.
Fumery, M.
Roblin, X.
Peyrin-Biroulet, L.
Filippi, J.
Bouguen, G.
Abitbol, V.
Coffin, B.
Simon, M.
Laharie, D.
Pariente, B.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 588 - 595
[30] Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience
Wils, P.
Bouhnik, Y.
Michetti, P.
Flourie, B.
Brixi, H.
Bourrier, A.
Allez, M.
Duclos, B.
Serrero, M.
Buisson, A.
Amiot, A.
Fumery, M.
Roblin, X.
Peyrin-Biroulet, L.
Filippi, J.
Bouguen, G.
Abitbol, V.
Coffin, B.
Simon, M.
Laharie, D.
Pariente, B.
JOURNAL OF CROHNS & COLITIS, 2017, 11 : S43 - S43

← 1 2 3 4 5 →